91精品国产手机在线-白筒袜嫩萝双腿之间乳白液体-青青操手机在线视频观看-日本中文字幕人妻日韩-日韩精品在线观看视频网站-天堂资源中文最新版在线一区-欧美专区一区二区三区-国产综合亚洲欧美在线-国产精品久久久久久福利69堂

專家論壇|尹明:HBV感染的動物模型研究進展( 五 )


[18]FARZA H, HADCHOUEL M, SCOTTO J, et al. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome[J]. J Virol, 1988, 62(11): 4144-4152. DOI: 10.1128/JVI.62.11.4144-4152.1988.
[19]GUIDOTTI LG, MATZKE B, SCHALLER H, et al. High-level hepatitis B virus replication in transgenic mice[J]. J Virol, 1995, 69(10): 6158-6169. DOI: 10.1128/JVI.69.10.6158-6169.
[20]CAVANAUGH VJ, GUIDOTTI LG, CHISARI FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice[J]. J Virol, 1997, 71(4): 3236-3243. DOI: 10.1128/JVI.71.4.3236-3243.1997.
[21]ISOGAWA M, ROBEK MD, FURUICHI Y, et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Virol, 2005, 79(11): 7269-7272. DOI: 10.1128/JVI.79.11.7269-7272.2005.
[22]UPRICHARD SL, BOYD B, ALTHAGE A, et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs[J]. Proc Natl Acad Sci U S A, 2005, 102(3): 773-778. DOI: 10.1073/pnas.0409028102.
[23]WINER BY, DING Q, GASKA JM, et al. In vivo models of hepatitis B and C virus infection[J]. FEBS Lett, 2016, 590(13): 1987-1999. DOI: 10.1002/1873-3468.12157.
[24]YANG PL, ALTHAGE A, CHUNG J, et al. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection[J]. Proc Natl Acad Sci U S A, 2002, 99(21): 13825-13830. DOI: 10.1073/pnas.202398599.
[25]DANDRI M, PETERSEN J. Animal models of HBV infection[J]. Best Pract Res Clin Gastroenterol, 2017, 31(3): 273-279. DOI: 10.1016/j.bpg.2017.04.014.
[26]HUANG LR, WU HL, CHEN PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J]. Proc Natl Acad Sci U S A, 2006, 103(47): 17862-17867. DOI: 10.1073/pnas.0608578103.
[27]YANG PL, ALTHAGE A, CHUNG J, et al. Immune effectors required for hepatitis B virus clearance[J]. Proc Natl Acad Sci U S A, 2010, 107(2): 798-802. DOI: 10.1073/pnas.0913498107.
[28]CHOU HH, CHIEN WH, WU LL, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota[J]. Proc Natl Acad Sci U S A, 2015, 112(7): 2175-2180. DOI: 10.1073/pnas.1424775112.
[29]SPRINZL MF, OBERWINKLER H, SCHALLER H, et al. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier[J]. J Virol, 2001, 75(11): 5108-5118. DOI: 10.1128/JVI.75.11.5108-5118.2001.
[30]von FREYEND MJ, UNTERGASSER A, ARZBERGER S, et al. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B[J]. J Viral Hepat, 2011, 18(3): 216-226. DOI: 10.1111/j.1365-2893.2010.01302.x.
[31]HARTMAN ZC, KIANG A, EVERETT RS, et al. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo[J]. J Virol, 2007, 81(4): 1796-1812. DOI: 10.1128/JVI.01936-06.
[32]YANG D, LIU L, ZHU D, et al. A mouse model for HBV immunotolerance and immunotherapy[J]. Cell Mol Immunol, 2014, 11(1): 71-78. DOI: 10.1038/cmi.2013.43.
[33]DION S, BOURGINE M, GODON O, et al. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules[J]. J Virol, 2013, 87(10): 5554-5563. DOI: 10.1128/JVI.03134-12.
[34]LIN SR, YANG HC, KUO YT, et al. The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo[J]. Mol Ther Nucleic Acids, 2014, 3: e186. DOI: 10.1038/mtna.2014.38.
[35]LUCIFORA J, SALVETTI A, MARNIQUET X, et al. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector[J]. Antiviral Res, 2017, 145: 14-19. DOI: 10.1016/j.antiviral.2017.07.006.
[36]DUAN D, SHARMA P, YANG J, et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue[J]. J Virol, 1998, 72(11): 8568-8577. DOI: 10.1128/JVI.72.11.8568-8577.1998.
[37]SU Y, ZHU YF, TIAN QY, et al. In vitro cell model and mouse model of HBV cccDNA[J]. J Clin Hepatol, 2019, 35(6): 1205-1211. DOI: 10.3969/j.issn.1001-5256.2019.06.007.
蘇瑜, 朱園飛, 田青右, 等. HBV cccDNA的體外細胞模型和實驗小鼠模型[J]. 臨床肝膽病雜志, 2019, 35(6): 1205-1211. DOI: 10.3969/j.issn.1001-5256.2019.06.007.
[38]GUO X, CHEN P, HOU X, et al. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely[J]. Sci Rep, 2016, 6: 25552. DOI: 10.1038/srep25552.
[39]QI Z, LI G, HU H, et al. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice[J]. J Virol, 2014, 88(14): 8045-8056. DOI: 10.1128/JVI.01024-14.
[40]KAY MA, HE CY, CHEN ZY. A robust system for production of minicircle DNA vectors[J]. Nat Biotechnol, 2010, 28(12): 1287-1289. DOI: 10.1038/nbt.1708.
[41]WU M, WANG C, SHI B, et al. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia[J]. Antiviral Res, 2020, 180: 104826. DOI: 10.1016/j.antiviral.2020.104826.

推薦閱讀